| 000 | 02043cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030725.0 | ||
| 008 | 121216s2012 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.11.32.M.Sc.2012.Am.A | ||
| 100 | 0 | _aAmira Ahmed Elgogary | |
| 245 | 1 | 0 |
_aAniti Mutated citrullinated vimentin antibodies in rheumatoid arthritis patients : _bRelation to disease activity and manifestations / _cAmira Ahmed Elgogary ; Supervised Somaya Anwar Hussein , Hala Zaki Raslan , Reem Ismail Elshazly |
| 246 | 1 | 5 | _aالاجسام المضادة للفمنتين المتحور السترولونى فى مرضى الالتهاب الروماتويدى المفصلى وعلاقتة بنشاط وأعراض المرض |
| 260 |
_aCairo : _bAmira Ahmed Elgogary , _c2012 |
||
| 300 |
_a154P. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Rheumatology and Rehabilitation | ||
| 520 | _aNumerous serological markers of RA have been described over the past 50 years . Among all these , Anti Citrullinated Protein\Peptide Antibodies (ACPA) have been proven to be specific , diagnostic and prognostic markers in RA . The newest member of this autoantibody family is Anti - Mutated Citrullinated Vimentin (MCV). The aim of this work was to evaluate the prevalence of Anti - Mutated Citrullinated Vimentin Antibodies (MCV) in rheumatoid arthritis patients and to correlate it with disease activity , various disease manifestations and prognosis | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aAniti-MCV antibodies | |
| 653 | 4 | _aRheumatoid arthritis | |
| 653 | 4 | _aVimentin antibodies | |
| 700 | 0 |
_aHala Zaki Raslan , _eSupervisor |
|
| 700 | 0 |
_aReem Ismail Elshazly , _eSupervisor |
|
| 700 | 0 |
_aSomaya Anwar Hussein , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aFatma _eCataloger |
||
| 905 |
_aNazla _eRevisor |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c40608 _d40608 |
||